These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11425277)

  • 1. Current prospects for controlling cancer growth with non-cytotoxic agents--nutrients, phytochemicals, herbal extracts, and available drugs.
    McCarty MF
    Med Hypotheses; 2001 Feb; 56(2):137-54. PubMed ID: 11425277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of dolichol synthesis with isoprenoids and statins may potentiate the cancer-retardant efficacy of IGF-I down-regulation.
    McCarty MF
    Med Hypotheses; 2001 Jan; 56(1):12-6. PubMed ID: 11133248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy.
    McCarty MF
    Integr Cancer Ther; 2004 Dec; 3(4):349-80. PubMed ID: 15523106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoxygenase metabolism: roles in tumor progression and survival.
    Pidgeon GP; Lysaght J; Krishnamoorthy S; Reynolds JV; O'Byrne K; Nie D; Honn KV
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):503-24. PubMed ID: 17943411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifocal angiostatic therapy: an update.
    McCarty MF; Block KI
    Integr Cancer Ther; 2005 Dec; 4(4):301-14. PubMed ID: 16282507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential therapeutic applications of some antinutritional plant secondary metabolites.
    Singh B; Bhat TK; Singh B
    J Agric Food Chem; 2003 Sep; 51(19):5579-97. PubMed ID: 12952405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
    Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
    Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A wholly nutritional 'multifocal angiostatic therapy' for control of disseminated cancer.
    McCarty MF
    Med Hypotheses; 2003 Jul; 61(1):1-15. PubMed ID: 12781633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current strategies for anticancer chemoprevention and chemoprotection.
    Krzystyniak KL
    Acta Pol Pharm; 2002; 59(6):473-8. PubMed ID: 12669776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity.
    Benavente-García O; Castillo J
    J Agric Food Chem; 2008 Aug; 56(15):6185-205. PubMed ID: 18593176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S; Inoue H; Flowers LC; Sidell N
    Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energy balance, physical activity, and cancer risk.
    Fair AM; Montgomery K
    Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CITED4 inhibits hypoxia-activated transcription in cancer cells, and its cytoplasmic location in breast cancer is associated with elevated expression of tumor cell hypoxia-inducible factor 1alpha.
    Fox SB; Bragança J; Turley H; Campo L; Han C; Gatter KC; Bhattacharya S; Harris AL
    Cancer Res; 2004 Sep; 64(17):6075-81. PubMed ID: 15342390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berry phytochemicals, genomic stability and cancer: evidence for chemoprotection at several stages in the carcinogenic process.
    Duthie SJ
    Mol Nutr Food Res; 2007 Jun; 51(6):665-74. PubMed ID: 17487926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyphenols and cancer cell growth.
    Kampa M; Nifli AP; Notas G; Castanas E
    Rev Physiol Biochem Pharmacol; 2007; 159():79-113. PubMed ID: 17551696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer phytotherapeutics: role for flavonoids at the cellular level.
    Kale A; Gawande S; Kotwal S
    Phytother Res; 2008 May; 22(5):567-77. PubMed ID: 18398903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of IGF-I production and proliferation of human leiomyomal smooth muscle cells by Scutellaria barbata D. Don in vitro: isolation of flavonoids of apigenin and luteolin as acting compounds.
    Kim DI; Lee TK; Lim IS; Kim H; Lee YC; Kim CH
    Toxicol Appl Pharmacol; 2005 Jun; 205(3):213-24. PubMed ID: 15922007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of 5-lipoxygenase product synthesis by natural compounds of plant origin.
    Werz O
    Planta Med; 2007 Oct; 73(13):1331-57. PubMed ID: 17939102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.